Residual crystals of triamcinolone acetonide in macular hole may prevent complete closure.
Koto
Takashi
T
Inoue
Makoto
M
Shinoda
Kei
K
Ishida
Susumu
S
Tsubota
Kazuo
K
D002648:Child; D003460:Crystallization; D005938:Glucocorticoids / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D008297:Male; D012167:Retinal Perforations / Q000378:metabolism / Q000503:physiopathology* / Q000601:surgery*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism* / Q000627:therapeutic use; D014821:Vitrectomy; D014822:Vitreous Body; D014945:Wound Healing
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide